AESARA

AESARA Names Denise Sánchez as Vice President of Regulatory Counsel and Compliance

AESARA Appoints Denise Sánchez as Vice President, Regulatory Counsel & Compliance Strategies AESARA, a leading Value & Access agency, announced that Denise Sánchez, JD, MS, MA, has joined the company as Vice President, Regulatory Counsel & Compliance Strategies. She served…

Read MoreAESARA Names Denise Sánchez as Vice President of Regulatory Counsel and Compliance
Infleqtion

Infleqtion Advances Fault-Tolerant Quantum Computing with NVIDIA CUDA-Q Logical

Infleqtion Advances Fault-Tolerant Quantum Computing Software with NVIDIA CUDA-Q Logical Infleqtion a global leader in quantum computing and quantum sensing powered by neutral-atom technology, announced results from its integration of NVIDIA CUDA-Q Logical with the qLDPC open-source library for quantum…

Read MoreInfleqtion Advances Fault-Tolerant Quantum Computing with NVIDIA CUDA-Q Logical
Vyriad Begins Phase 1 Clinical Trial for Lead In Vivo CAR T Cell Therapy VV169 Following FDA Acceptance of IND Application

Vyriad Launches Phase 1 Trial of VV169 In Vivo CAR T Cell Therapy After FDA IND Clearance

Vyriad Begins Phase 1 Clinical Trial for Lead In Vivo CAR T Cell Therapy VV169 Following FDA Acceptance of IND Application Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, today announced that…

Read MoreVyriad Launches Phase 1 Trial of VV169 In Vivo CAR T Cell Therapy After FDA IND Clearance
IMCD

IMCD to Present Innovative Formulation Concepts and Sensory Solutions at In-Cosmetics Latin America 2026

IMCD to showcase formulation concepts and sensory experience at In-Cosmetics Latin America 2026 IMCD Group a leading global partner for the distribution and formulation of speciality chemicals and ingredients, will be exhibiting at In-Cosmetics Latin America 2026, on 23 and…

Read MoreIMCD to Present Innovative Formulation Concepts and Sensory Solutions at In-Cosmetics Latin America 2026
Estée

Indianapolis Community Unites to Take Action Against Breast Cancer at Susan G. Komen® MORE THAN PINK Walk

Breast Cancer Continues to Impact Communities; Indianapolis Rallies Together to Take Action at the Susan G. Komen® MORE THAN PINK Walk Susan G. Komen®, the world’s leading breast cancer organization, announced it will host the Indianapolis MORE THAN PINK Walk bringing together…

Read MoreIndianapolis Community Unites to Take Action Against Breast Cancer at Susan G. Komen® MORE THAN PINK Walk
Invivoscribe

Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems for High-Sensitivity MRD Testing

Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, announced that commercial shipments of the PrepQuant™ System have begun in North America. First…

Read MoreInvivoscribe Begins Commercial Shipments of PrepQuant™ Systems for High-Sensitivity MRD Testing
Gabrail Cancer

Gabrail Cancer Center Launches Study of Elranatamab and Low-Dose Lenalidomide Combination

The Gabrail Cancer Center Undertakes Investigator-Initiated Study Evaluating the T-Cell Engager Elranatamab in Combination with Starton Therapeutics’ Controlled Low-Dose Lenalidomide The Gabrail Cancer and Research Center, a PhaseWell Research site, announced that Nashat Gabrail, M.D., has received notification from the…

Read MoreGabrail Cancer Center Launches Study of Elranatamab and Low-Dose Lenalidomide Combination
Naturmega

Naturmega to Debut SUPRIAX2™ Solution in North America at SupplySide Global 2026

Naturmega’s SUPRIAX2™ Solution to Make Its North American Debut at SupplySide Global 2026 Naturmega, an advanced lipid science company specializing in omega-3 and next-generation lipid technologies, will introduce SUPRIAX2™ to the North American market at SupplySide Global 2026 in Las…

Read MoreNaturmega to Debut SUPRIAX2™ Solution in North America at SupplySide Global 2026
GE HealthCare

GE HealthCare’s Photonova™ Spectra Receives CE Mark, Expanding Global Access

GE HealthCare’s Photonova™ Spectra gains CE Mark, expanding international access GE HealthCare recently achieved CE Mark for Photonova Spectra,i an advanced photon-counting computed tomography (PCCT) system with the company’s proprietary Deep Silicon™ detector technology. The regulatory milestone expands access and enables…

Read MoreGE HealthCare’s Photonova™ Spectra Receives CE Mark, Expanding Global Access
Yangi

Yangi Brings Cellera® Dry-Forming Technology to U.S. Converters Amid Tariff Changes

As Tariffs Reshape the Molded Fiber Market, Yangi Brings Its Dry-Forming Technology Cellera® to U.S. Converters Yangi, the Swedish developer of Cellera®, a dry-forming technology for fiber-based packaging, is entering the U.S. market with its quick-serve packaging range, as part of…

Read MoreYangi Brings Cellera® Dry-Forming Technology to U.S. Converters Amid Tariff Changes